ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Biocure Technology Inc (PK)

Biocure Technology Inc (PK) (BICTF)

0.63
0.00
(0.00%)
마감 14 1월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.63
매수가
0.0012
매도가
0.63
거래량
-
0.00 일간 변동폭 0.00
0.045 52주 범위 0.63
market_cap
전일 종가
0.63
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
10,444,504
배당수익률
-
주가수익률
-3.63
주당순이익(EPS)
-0.17
매출
-
순이익
-1.81M

Biocure Technology Inc (PK) 정보

섹터
Ferroalloy Ores, Ex Vanadium
산업
Business Services, Nec
웹사이트
본부
Vancouver, British Columbia, Can
설립됨
2010
Biocure Technology Inc (PK) is listed in the Ferroalloy Ores, Ex Vanadium sector of the OTC 시장 with ticker BICTF. The last closing price for Biocure Technology (PK) was US$0.63. Over the last year, Biocure Technology (PK) shares have traded in a share price range of US$ 0.045 to US$ 0.63.

Biocure Technology (PK) currently has 10,444,504 shares in issue. The market capitalisation of Biocure Technology (PK) is US$6.58 million. Biocure Technology (PK) has a price to earnings ratio (PE ratio) of -3.63.

BICTF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
26000.630.630.045830.045CS
52000.630.630.045420.045CS
156-0.0351-5.277401894450.66510.720.031563150.31210111CS
260-1.4076-69.08127208482.03762.27250.031536260.88475648CS

BICTF - Frequently Asked Questions (FAQ)

What is the current Biocure Technology (PK) share price?
The current share price of Biocure Technology (PK) is US$ 0.63
How many Biocure Technology (PK) shares are in issue?
Biocure Technology (PK) has 10,444,504 shares in issue
What is the market cap of Biocure Technology (PK)?
The market capitalisation of Biocure Technology (PK) is USD 6.58M
What is the 1 year trading range for Biocure Technology (PK) share price?
Biocure Technology (PK) has traded in the range of US$ 0.045 to US$ 0.63 during the past year
What is the PE ratio of Biocure Technology (PK)?
The price to earnings ratio of Biocure Technology (PK) is -3.63
What is the reporting currency for Biocure Technology (PK)?
Biocure Technology (PK) reports financial results in CAD
What is the latest annual profit for Biocure Technology (PK)?
The latest annual profit of Biocure Technology (PK) is CAD -1.81M
What is the registered address of Biocure Technology (PK)?
The registered address for Biocure Technology (PK) is 300, 1055 WEST HASTINGS STREET, VANCOUVER, BRITISH COLUMBIA, V6E 2E9
What is the Biocure Technology (PK) website address?
The website address for Biocure Technology (PK) is www.biocuretech.com
Which industry sector does Biocure Technology (PK) operate in?
Biocure Technology (PK) operates in the BUSINESS SERVICES, NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
VICPVicapsys Life Sciences Inc (CE)
US$ 1.50
(149,999,900.00%)
207
CRSQCorporate Restaurant Concepts Inc (PK)
US$ 0.99
(82,400.00%)
500
PSRUValiant Eagle Inc (PK)
US$ 0.0002
(19,900.00%)
42.27M
CCTLCoin Citadel (PK)
US$ 0.0002
(19,900.00%)
100k
MOPNMOP Environmental Solutions Inc (CE)
US$ 0.0001
(9,900.00%)
32k
INOQTPT Strategic Inc (CE)
US$ 0.000001
(-100.00%)
500
VGTLVGTel Inc (CE)
US$ 0.000001
(-99.50%)
200k
IFANIFAN Financial Inc (CE)
US$ 0.000001
(-99.50%)
1,000
VAXXVaxxinity Inc (CE)
US$ 0.0004
(-99.20%)
15.6k
GLCOGlobal Links Corporation New (CE)
US$ 0.000001
(-99.00%)
1.5k
PHILPHI Group Inc (PK)
US$ 0.0003
(20.00%)
350.65M
ABQQAB International Group Corporation (PK)
US$ 0.0007
(0.00%)
227.81M
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
200.68M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0037
(-1.33%)
141.32M
RDARRaadr Inc (PK)
US$ 0.0012
(4.35%)
138.46M
Golden Cross Golden Cross 29 초 전
💎 $ILLR Many Reasons To Like Triller Now⬇️

~ Launch of Triller 5.0 App.
~ New Streaming Acquisition News Soon
~ Multiple Revenue Streams.
~ New CEO of Triller App is former TikTok executive Sean Kim.
~ TikTok US ban starts 1-19, 2025. Federal cour
ILLR
kspar1 kspar1 2 분 전
Wow! I had no idea the JPM conference in San Francisco is as energetic as this link reads, including the partnership announcements. Will be fun to see how Anavex is positioned. The conference supposed to generate $92M for the city.
https://www.fiercebiotech.com/biotech/jpm25-day-1-fierce-bio
JPM
Frankestin Frankestin 3 분 전
Truist Securities raises PT to $180 from $150 😮
The next two weeks will be eventful
AXS-07, a candidate for the acute treatment of migraines, with expectations for regulatory approval
NDA for AXS-14 for fibromyalgia... maybe yes or maybe no
AXSM
Number sleven Number sleven 7 분 전
https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amarin-pharma-inc/?page=2
Sleven,
AMRN
price_and_volume price_and_volume 11 분 전
"Right news" gonna get $175-350MM market cap? LOL!

Omg what a maroon.
VXIT
The Danish Dude The Danish Dude 11 분 전
Nice and interesting analysis, but completely irrelevant >!

I fed ChatGPT the following five comments regarding this analysis and it disagrees with you.

I saw these comments regarding how MHRA approves or rejects medecines at mhra meetings

1
NWBO
lakers17 lakers17 12 분 전
MTC back to $96,000 after hitting $89, 200s yesterday. Cryptos I added to in the last couple of days were BOBO, PAI, OTTO and CLUSTR. RING AI looking better. Boom or bust for me.
MTC
Golden Cross Golden Cross 15 분 전
Loading Zone Here! $ASII
ASII
Hi_Lo Hi_Lo 24 분 전
Where is the CSE press release filing?

TWOH has been halted for more than a week now and the CSE press release is still missing.

Could the run up before the halt be the problem?

Could some people have been tipped off before the run up?

Coul
TWOH
SkeBallLarry SkeBallLarry 32 분 전
https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/473323273_992397186268896_4170433101098362110_n.jpg?_nc_cat=100&ccb=1-7&_nc_sid=833d8c&_nc_ohc=UebR9WKXEXsQ7kNvgELlMGV&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AvB9U-Cb1bfWGguzkXzMzar&oh=00_AYDqG-tA0ScuUz90hSjz11X1LQL5aezyuhOfdBXmp9pGuQ&oe=678C04
Dodger1 Dodger1 33 분 전
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652942 I Miss Real
AABB
jondoeuk jondoeuk 36 분 전
NEUK201-00* is being tested in advanced/metastatic solid tumours at a single site.

https://i.postimg.cc/fyWcxcwj/download.png

* It could be an iNK with just a high-affinity non-cleavable CD16(a) receptor, but this comes from a Chinese site that has under
HPQ
marcis marcis 38 분 전
I was just thinking the same thing

Go bother those serial OTC stock hijackers
( we know them all well ) that’s been doing LOI mergers, asset ( no asset ) transfers for years with never a real company.
( not you Prophet, to the shills )
Save those investors
RDAR
No-Quarter No-Quarter 38 분 전
Good to know, thx!
LetGoodTimesRoll LetGoodTimesRoll 39 분 전
The criminality surrounding BLUE Sheets data is rampant...

https://www.sec.gov/newsroom/press-releases/2025-5?utm_medium=email&utm_source=govdelivery
FOXO
Seminole Red Seminole Red 39 분 전
https://scontent-mia3-2.xx.fbcdn.net/v/t39.30808-6/472742874_1004087688423643_1614366062036311373_n.jpg?_nc_cat=1&ccb=1-7&_nc_sid=833d8c&_nc_ohc=nfcGrMsEIhAQ7kNvgF3nw1U&_nc_zt=23&_nc_ht=scontent-mia3-2.xx&_nc_gid=AZgGdnGS_3zIT8EnJ2PY5KX&oh=00_AYA_PYWQyRmy2OxdvryhKxL8uHQSf69FZtEDZ_CZJ06VFQ&oe=678BF3D
Bubae Bubae 39 분 전
New shares flying everywhere from the looks of the filings. Form 144 filed on January 10th by Atlas Merchant Capital LLC intent to sell 1,241,144 shares. approximate date of sale listed as 01/10/2025. Robert E. Diamond, Triller Chairman of the Board, Chief Executive Officer of Atlas Merchant Capita
ILLR
meshcan meshcan 41 분 전
Yes, hence I was saying the really numbers will be in a couple quarters from now, August CC will be two full quarters that we have Vyvanse sell numbers.

CC: NASDAC2020
ELTP
PlaneReflection PlaneReflection 42 분 전
Remember when you said it won't pass $2 again?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174119656

Please say it won't pass $10 again, $30 again and it'll never be over $200. Thanks.
FNMA
eagle8 eagle8 43 분 전
ATLnsider
@ATLnsider
Global future for $NWBO #DCVax dendritic cell vaccine platform could be unlimited if efficacy is proven to be tumor & tissue agnostic for all solid tumor cancers & when combined with checkpoint inhibitors can also effectively treat all blood or liquid cancers. NWBi
NWBO
PROPHET-of-PROFITS PROPHET-of-PROFITS 44 분 전
The old CEO of rdar has a new stock already to transfer all of his garbage into. But you watch the bearish comments here Will Never follow Jacob to that new stock where efforts should be made to protect people from making a bad investment. Negative bearish comments and all the effort to create them
RDAR
Pickme2 Pickme2 45 분 전
The only proof here is you constantly saying this is the best setup and challenge...yet it keeps going down down from .31 cents to .03 ...now .05  and despite the company saying this S-1 offering filled with the SEC will cause dilution and shareholders will have a hard time selling...you continue to
ATMH
PC retired PC retired 47 분 전
Yes, it has gone deathly quiet. I have little to say other than wishing you, Richard H2, a happy and prosperous new year.
ASRE

최근 히스토리

Delayed Upgrade Clock